Physician profile
Robert A Helft
NPI 1871515304
$608.79
in general payments reported to CMS, 2019-2025
10 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $501 · 2020: $44.04 · 2022: $44.37 · 2023: $19.06.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $19.06.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $19.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ucb, INC. | $183.55 | 2019 | |
| Janssen Biotech, INC. | $135.53 | 2019-2020 | |
| Abbvie INC. | $91.34 | 2019 | |
| Gilead Sciences, INC. | $74.64 | 2019-2023 | |
| Takeda Pharmaceuticals U.S.A., INC. | $31.65 | 2019 | |
| Concordia Pharmaceuticals INC. | $27.78 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $22.41 | 2019 | |
| Qol Medical, LLC | $15.47 | 2019 | |
| Cook Medical LLC | $14.73 | 2022 | |
| Janssen Pharmaceuticals, INC | $11.69 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Helft listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.